Bone Marrow Transplantation - Figure 2 for article: Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease

FROM:

Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease

H Church, K Tylee, A Cooper, M Thornley, J Mercer, E Wraith, T Carr, A O'Meara and R F Wynn

Figure 2.

Next figurePrevious figureFigure and tables index

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

A biochemical profile of an MPS patient who has undergone HSCT. The donor here is a normal related donor, and there is full donor cell engraftment. Leucocyte -iduronidase activity shows natural fluctuation within the normal range. Residual GAGs have fallen in the initial 6 month period post-transplant, reaching a plateau that shows a DS/CS ratio consistently <0.5. These data are typical of patients showing full engraftment from normal donors.

Next figurePrevious figureFigure and tables index

BACK TO ARTICLE

FIGURE 2

Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease

Figure 2.